Return to search results
Fenofibrate
Fenofibrate is a prescription medication that helps lower high cholesterol and triglyceride levels in the blood. It works by activating certain receptors to improve lipid metabolism. Available as oral tablets in 54mg and 160mg strengths, it's manufactured by Alembic Pharmaceuticals under the brand name Fenofibrate. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Fenofibrate is a prescription medication that helps lower high cholesterol and triglyceride levels in the blood. It works by activating certain receptors to improve lipid metabolism. Available as oral tablets in 54mg and 160mg strengths, it's manufactured by Alembic Pharmaceuticals under the brand name Fenofibrate. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Fenofibrate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Fenofibrate — ANDA 207803 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207803"
}
]
|
| identifier | ANDA207803 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"fda",
"health-care"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Fenofibrate |
